Biocon reports 19% fall in Q4 consolidated net profit

29 Apr 2022 Evaluate

Biocon has reported results for fourth quarter and year ended March 31, 2022.

The company has reported a fall of 43.72% in its net profit at Rs 38.10 crore for the quarter under review as compared to Rs 67.70 crore for the same quarter in the previous year. However, total income of the company increased by 7.83% at Rs 578.50 crore for Q4FY22 as compared Rs 536.50 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 19.40% in its net profit at Rs 238.90 crore for the quarter under review as compared to Rs 296.40 crore for the same quarter in the previous year. However, total income of the company increased by 20.93% at Rs 2,476.10 crore for Q4FY22 as compared Rs 2,047.50 crore for the corresponding quarter previous year.

For the year ended March 31, 2022, the company has reported a fall of 69.30% in its net profit at Rs 86.10 crore as compared to Rs 280.50 crore for the previous year. Total income of the company decreased by 11.62% at Rs 1,925.40 crore for year under review as compared to Rs 2,178.60 crore for year ended March 31, 2021.

For the year ended March 31, 2022, on the consolidated basis, the company has reported a fall of 8.82% in its net profit at Rs 771.60 crore as compared to Rs 846.20 crore for the previous year. Total income of the company increased by 13.51% at Rs 8,396.70 crore for year under review as compared to Rs 7,397.60 crore for year ended March 31, 2021.

Biocon Share Price

395.25 -2.80 (-0.70%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×